EP 4106760 A4 20240327 - COMBINATIONS
Title (en)
COMBINATIONS
Title (de)
KOMBINATIONEN
Title (fr)
ASSOCIATIONS
Publication
Application
Priority
- US 202063021290 P 20200507
- US 2021030931 W 20210505
Abstract (en)
[origin: WO2021226263A1] Disclosed herein are combination therapies of Bcl-2 inhibitors (Compound (A), along with pharmaceutically acceptable salts thereof) and CDK 4/6 inhibitors (Compound (B), along with pharmaceutically acceptable salts thereof) for treating a disease or condition, such as a cancer, including breast cancer and leukemia.
IPC 8 full level
A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5355 (2006.01); A61K 31/5377 (2006.01); A61K 31/635 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC (source: AU EP IL KR US)
A61K 31/496 (2013.01 - AU EP KR US); A61K 31/506 (2013.01 - EP US); A61K 31/519 (2013.01 - AU EP IL KR US); A61K 31/52 (2013.01 - EP IL KR); A61K 31/5355 (2013.01 - AU EP); A61K 31/5377 (2013.01 - EP KR); A61K 31/635 (2013.01 - EP US); A61K 45/06 (2013.01 - EP KR); A61P 35/00 (2018.01 - AU EP IL KR US); A61P 35/02 (2018.01 - EP KR); A61K 2300/00 (2013.01 - AU IL KR)
C-Set (source: AU EP)
AU
EP
Citation (search report)
- [Y] WO 2019139900 A1 20190718 - ZENO ROYALTIES & MILESTONES LLC [US]
- [Y] WO 2019245974 A1 20191226 - GENENTECH INC [US], et al
- [E] WO 2022133446 A1 20220623 - RECURIUM IP HOLDINGS LLC [US]
- See also references of WO 2021226263A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021226263 A1 20211111; AU 2021268195 A1 20220929; CA 3174700 A1 20211111; CN 115666574 A 20230131; EP 4106760 A1 20221228; EP 4106760 A4 20240327; IL 297960 A 20230101; JP 2023525022 A 20230614; KR 20230007360 A 20230112; MX 2022010801 A 20221130; TW 202207920 A 20220301; US 2023158048 A1 20230525
DOCDB simple family (application)
US 2021030931 W 20210505; AU 2021268195 A 20210505; CA 3174700 A 20210505; CN 202180033338 A 20210505; EP 21800325 A 20210505; IL 29796022 A 20221106; JP 2022567440 A 20210505; KR 20227038408 A 20210505; MX 2022010801 A 20210505; TW 110116613 A 20210507; US 202117997807 A 20210505